Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

NCT04405401 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer Metastatic

Interventions

RADIATION: SABR
OTHER: Standard of care

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)